AlphaYouMW
Fund 13F filing
Marshall Wace added $81M of Spyre Therapeutics, Inc. (SYRE) stock
Marshall Wace added $81M of Spyre Therapeutics, Inc. (SYRE) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 13, 2026.
A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.
- Disclosed
- Aug 13, 2026
- Quarter end
- Jun 30, 2026
- Source
- SEC Form 13F
More SYRE insider and Congress trades
From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.